Seeing Is Believing
UNCY is currently covered by 4 analysts with an average price target of $3.78. This is a potential upside of $3.23 (587.27%) from yesterday's end of day stock price of $0.55.
Unicycive Therapeutics's activity chart (see below) currently has 2 price targets and 18 ratings on display. The stock rating distribution of UNCY is 100% BUY.
Highest price target for UNCY is $4.5, Lowest price target is $4.5, average price target is $4.17.
Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 14-May-2024. First documented stock forecast 09-Aug-2021.
Currently out of the existing stock ratings of UNCY, 16 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4.5
$3.49 (345.54%)
$4.5
11 months 27 days ago
(14-May-2024)
0/5 (0%)
$3.41 (312.84%)
Buy
$3
$1.99 (197.03%)
$3
1 years 26 days ago
(15-Apr-2024)
0/3 (0%)
$1.86 (163.16%)
Buy
$5
$3.99 (395.05%)
$5
1 years 10 months 11 days ago
(30-Jun-2023)
0/5 (0%)
$3.72 (290.63%)
Buy
$6
$4.99 (494.06%)
$3
2 years 2 months 2 days ago
(09-Mar-2023)
0/2 (0%)
$3.94 (191.26%)
What is UNCY (Unicycive Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on UNCY (Unicycive Therapeutics) with a proven track record?
Which analyst has the current lower performing score on UNCY (Unicycive Therapeutics) with a proven track record?
Which analyst has the most public recommendations on UNCY (Unicycive Therapeutics)?
Which analyst is the currently most bullish on UNCY (Unicycive Therapeutics)?
Which analyst is the currently most reserved on UNCY (Unicycive Therapeutics)?